David Calvello

David Calvello is a Partner in Faruqi & Faruqi, LLP’s New York office.  He mainly practices in the area of antitrust litigation with a focus on competition in the pharmaceutical industry.  He has worked on multiple cases that resulted in significant settlements, including In re Lidoderm Antitrust Litigation, 14-md-02521 (N.D. Cal.) ($166M settlement), In re Loestrin 24 Antitrust Litigation, 13-md-2472 (D.R.I.) ($120M settlement), and In re Solodyn Antitrust Litigation, 14-md-2503 (D. Mass.) ($76M settlement).

Mr. Calvello graduated from Pace Law School (J.D., magna cum laude, 2014) and from the University of Richmond (B.S., 2011) with a double major in Finance and Political Science.  In law school, Mr. Calvello served as an associate editor on the Pace International Law Review and received the New Rochelle Bar Association Award upon graduation.  He also competed in the Willem C. Vis International Commercial Arbitration Moot in Vienna, Austria.

Mr. Calvello is licensed to practice law in New York and New Jersey and is admitted to practice before the United States District Court for New Jersey and the Southern and Eastern Districts of New York.